Immunotherapy Moves to the Early-Stage Setting in Non-Small Cell Lung Cancer: Emerging Evidence and the Role of Biomarkers

SIMPLE SUMMARY: In recent years there has been a trend towards an increase in the proportion of non-small cell lung cancer patients diagnosed with localized stage instead of advanced. However, 5-year survival rates continue to be low, even among patients diagnosed at early stages. In recent years ma...

Descripción completa

Detalles Bibliográficos
Autores principales: Mielgo-Rubio, Xabier, Calvo, Virginia, Luna, Javier, Remon, Jordi, Martín, Margarita, Berraondo, Pedro, Jarabo, José Ramón, Higuera, Oliver, Conde, Esther, De Castro, Javier, Provencio, Mariano, Hernando Trancho, Florentino, López-Ríos, Fernando, Couñago, Felipe
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2020
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7699975/
https://www.ncbi.nlm.nih.gov/pubmed/33233705
http://dx.doi.org/10.3390/cancers12113459

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7699975/
https://www.ncbi.nlm.nih.gov/pubmed/33233705
http://dx.doi.org/10.3390/cancers12113459

Ejemplares similares